A detailed history of Northern Trust Corp transactions in Savara Inc stock. As of the latest transaction made, Northern Trust Corp holds 987,790 shares of SVRA stock, worth $3.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
987,790
Previous 791,897 24.74%
Holding current value
$3.16 Million
Previous $3.19 Million 31.24%
% of portfolio
0.0%
Previous 0.0%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$3.96 - $5.07 $775,736 - $993,177
195,893 Added 24.74%
987,790 $4.19 Million
Q2 2024

Aug 14, 2024

SELL
$3.66 - $5.34 $41,218 - $60,139
-11,262 Reduced 1.4%
791,897 $3.19 Million
Q1 2024

May 14, 2024

BUY
$4.19 - $5.59 $34,567 - $46,117
8,250 Added 1.04%
803,159 $4 Million
Q4 2023

Feb 13, 2024

BUY
$3.18 - $4.9 $152,382 - $234,803
47,919 Added 6.41%
794,909 $3.74 Million
Q3 2023

Nov 13, 2023

BUY
$2.97 - $3.88 $338,986 - $442,851
114,137 Added 18.04%
746,990 $2.82 Million
Q2 2023

Aug 11, 2023

BUY
$1.69 - $3.24 $818,409 - $1.57 Million
484,266 Added 325.91%
632,853 $2.02 Million
Q1 2023

May 15, 2023

BUY
$1.6 - $2.82 $17,924 - $31,592
11,203 Added 8.15%
148,587 $289,000
Q4 2022

Feb 13, 2023

SELL
$1.11 - $1.64 $37,125 - $54,851
-33,446 Reduced 19.58%
137,384 $212,000
Q3 2022

Nov 14, 2022

SELL
$1.36 - $1.88 $1,944 - $2,688
-1,430 Reduced 0.83%
170,830 $265,000
Q2 2022

Aug 12, 2022

SELL
$1.1 - $1.58 $1,976 - $2,839
-1,797 Reduced 1.03%
172,260 $262,000
Q1 2022

May 13, 2022

SELL
$1.05 - $1.36 $1,446 - $1,874
-1,378 Reduced 0.79%
174,057 $228,000
Q4 2021

Feb 08, 2022

SELL
$1.04 - $1.34 $93 - $120
-90 Reduced 0.05%
175,435 $217,000
Q3 2021

Nov 15, 2021

SELL
$1.18 - $1.64 $22,967 - $31,920
-19,464 Reduced 9.98%
175,525 $242,000
Q2 2021

Aug 13, 2021

SELL
$1.51 - $2.29 $415,228 - $629,717
-274,986 Reduced 58.51%
194,989 $331,000
Q1 2021

May 12, 2021

SELL
$1.17 - $2.33 $40,945 - $81,540
-34,996 Reduced 6.93%
469,975 $977,000
Q4 2020

Feb 11, 2021

SELL
$1.0 - $1.47 $15,292 - $22,479
-15,292 Reduced 2.94%
504,971 $580,000
Q3 2020

Nov 16, 2020

BUY
$1.09 - $2.21 $8,827 - $17,898
8,099 Added 1.58%
520,263 $567,000
Q2 2020

Aug 14, 2020

BUY
$1.8 - $3.05 $197,083 - $333,947
109,491 Added 27.19%
512,164 $1.28 Million
Q1 2020

May 14, 2020

BUY
$1.91 - $4.08 $63,377 - $135,382
33,182 Added 8.98%
402,673 $854,000
Q4 2019

Feb 14, 2020

SELL
$0.71 - $4.91 $33,352 - $230,652
-46,976 Reduced 11.28%
369,491 $1.66 Million
Q3 2019

Nov 13, 2019

BUY
$2.16 - $3.2 $156,148 - $231,331
72,291 Added 21.0%
416,467 $1.1 Million
Q2 2019

Aug 13, 2019

BUY
$2.37 - $11.7 $12,020 - $59,342
5,072 Added 1.5%
344,176 $815,000
Q1 2019

May 13, 2019

SELL
$6.71 - $8.6 $64,952 - $83,248
-9,680 Reduced 2.78%
339,104 $2.5 Million
Q4 2018

Feb 12, 2019

SELL
$6.27 - $10.92 $2,990 - $5,208
-477 Reduced 0.14%
348,784 $2.64 Million
Q3 2018

Nov 14, 2018

BUY
$10.49 - $12.87 $683,413 - $838,467
65,149 Added 22.93%
349,261 $3.9 Million
Q2 2018

Aug 14, 2018

BUY
$8.55 - $13.76 $1.93 Million - $3.1 Million
225,582 Added 385.41%
284,112 $3.22 Million
Q1 2018

May 09, 2018

BUY
$8.99 - $14.95 $96,903 - $161,146
10,779 Added 22.57%
58,530 $539,000
Q4 2017

Feb 14, 2018

BUY
$8.26 - $16.76 $394,423 - $800,306
47,751
47,751 $708,000

Others Institutions Holding SVRA

About Savara Inc


  • Ticker SVRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,043,000
  • Market Cap $365M
  • Description
  • Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases. Its lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase III development stage for the treatment of autoimmune pulmonary alveolar proteinosis. The company is headquartered in Austin, Texas.
More about SVRA
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.